|
"dudek arkadiusz z"的相关文件
显示项目 1-3 / 3 (共1页) 1 每页显示[10|25|50]项目
國立成功大學 |
2012-05 |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
|
Yang, James Chih-Hsin; Shih, Jin-Yuan; Su, Wu-Chou; Hsia, Te-Chun; Tsai, Chun-Ming; Ou, Sai-Hong Ignatius; Yu, Chung-Jen; Chang, Gee-Chen; Ho, Ching-Liang; Sequist, Lecia V.; Dudek, Arkadiusz Z.; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, Pan-Chyr; Miller, Vincent A. |
國立臺灣大學 |
2012 |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
|
Yang, James Chih-Hsin; Shih, Jin-Yuan; Su, Wu-Chou; Hsia, Te-Chun; Tsai, Chun-Ming; Ou, Sai-Hong Ignatius; Yu, Chung-Jen; Chang, Gee-Chen; Ho, Ching-Liang; Sequist, Lecia V.; Dudek, Arkadiusz Z.; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, Pan-Chyr; Miller, Vincent A.; 楊志新; 楊泮池; 余忠仁; 施金元 |
國立成功大學 |
2009-09 |
BIBW 2992, a novel irreversible EGFR/HER2 tyrosine kinase inhibitor, in chemonaive patients with adenocarcinoma of the lung and activating EGFR mutations
|
Yang Chih-Hsin; Shih Jin-Yuan; Su Wu-Chou; Hsia Te-Chun; Ho Ching-Liang; Dudek, Arkadiusz Z.; Terlizzi, Elizabeth; Zhao Yihua M; Shahidi, Mehdi; Miller, Vincent A. |
显示项目 1-3 / 3 (共1页) 1 每页显示[10|25|50]项目
|